Jiangbo’s persistent strategy for R & D is to commit ourselves to cooperation and collaborations  with domestic renowned research institutes, and also to the enlargement of such corporations to strengthen our core competitive abilities. 

Jiangbo has established strategic partnerships with many research institutions in China, such as The Institute of Microbiology, Chinese Academy of Sciences(“IMCAS”); Pharmaceutical Institute of Shandong University and Shandong Chinese Traditional Medicine Technical School, which greatly conduce to the development of  a continuing new high-quality drugs  in the future.

In November, 2006, Jiangbo signed an agreement with IMCAS to mutually build a joint base of industrialization for the promotion of biological medicine industry. Such cooperation enhanced the ability of Jiangbo to seize the dynamics of biological medicines and ensured its acquisition of promising medicines. In addition, Jiangbo provides internship base for Shandong Traditional Chinese Medicine Technical School.